| 1 | Technology | XLK | +28.1% |
| 2 | Energy | XLE | +26.1% |
| 3 | Materials | XLB | +13.1% |
| 4 | Real Estate | XLRE | +12.3% |
| 5 | Industrials | XLI | +11.5% |
| 6 | Consumer Staples | XLP | +10.5% |
| 7 | Utilities | XLU | +3.1% |
| 8 | Healthcare | XLV | -1.1% |
| 9 | Consumer Disc. | XLY | -1.5% |
| 10 | Financials | XLF | -2.9% |
| 11 | Communication | XLC | -4.5% |
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. …
| Qtr | Date | EPS Est | Act | Δ | YoY | Rev Est | Act | Δ | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Q1 '26 | 5/5/26 | $0.74 | $0.87 | +17.6% | +40% | $0.6B | $0.6B | +0.7% | +10% |
| Q4 '25 | 2/10/26 | $0.76 | $0.94 | +23.7% | +71% | $0.6B | $0.6B | +0.7% | +6% |
| Q3 '25 | 11/4/25 | $0.63 | $0.78 | +23.8% | +66% | $0.6B | $0.6B | +1.4% | +11% |
| Q2 '25 | 7/28/25 | $0.61 | $0.75 | +22.9% | -11% | $0.6B | $0.6B | -1.6% | -11% |
| Q1 '25 | 5/13/25 | $0.44 | $0.62 | +40.9% | +265% | $0.5B | $0.6B | +10.9% | +31% |